PMID- 9262374 OWN - NLM STAT- MEDLINE DCOM- 19970911 LR - 20171116 IS - 0022-3565 (Print) IS - 0022-3565 (Linking) VI - 282 IP - 2 DP - 1997 Aug TI - Interaction of ethanol with inducible nitric oxide synthase messenger RNA and protein: direct effects on autacoids and endotoxin in vivo. PG - 1044-54 AB - Inducible nitric oxide synthase (iNOS) mRNA is up-regulated in vivo by dibutyryl-cAMP (db-cAMP), the purine-2y receptor agonist 2-methylthio-ATP and Escherichia coli endotoxin lipopolysaccharide (LPS). Ethanol and diethyldithiocarbamate inhibit LPS-stimulated iNOS mRNA. Their effects on db-cAMP- and 2-methylthio-ATP-stimulated iNOS mRNA remain undefined. We examined the effect of ethanol (4.5 g/kg intraperitoneal) and intratracheal diethyldithiocarbamate (5 mg/kg) on intratracheal LPS (0.6 mg/kg), db-cAMP (0.1 and 1 mg/kg) or 2-methylthio-ATP (5 mg/kg)-stimulated rat alveolar macrophage (AM) iNOS mRNA and protein, reactive nitrogen intermediates nitrite and nitrate anion (RNI) and nuclear transcription factor-kappaB (NF-kappaB) in vivo. LPS and the autacoids increased iNOS mRNA and protein in rat AM and RNI in bronchoalveolar lavage fluid and in ex vivo incubates of AM compared with these parameters in control rats (n = 6-21/group). Only LPS up-regulated TNF-alpha mRNA and release of TNF-alpha in bronchoalveolar lavage fluid and AM. Ethanol inhibited LPS stimulation of the iNOS cascade at the level of transcription but inhibited only autacoid-stimulated iNOS protein and RNI. Diethyldithiocarbamate selectively inhibited the LPS-stimulated iNOS cascade at the level of transcription. Coadministration of ethanol and diethyldithiocarbamate inhibited LPS-stimulated iNOS mRNA, protein and RNI more than either inhibitor alone but did not differ from ethanol alone on autacoid-stimulated iNOS protein or RNI. LPS increased and db-cAMP did not affect NF-kappaB in AM. Ethanol inhibited LPS-stimulated NF-kappaB. Thus, two distinct pathways exist for induction of iNOS mRNA in rat AM in vivo: an NF-kappaB pathway for LPS and cytokines inhibitable by ethanol and diethyldithiocarbamate and an NF-kappaB-independent pathway, refractory to inhibition by ethanol and diethyldithiocarbamate for db-cAMP and 2-mes-ATP. Finally, ethanol inhibits iNOS at the level of transcription and at the level of the enzyme. FAU - Greenberg, S S AU - Greenberg SS AD - Department of Medicine, The LSUMC Cardiovascular Center of Excellence, Louisiana State University Medical Center, New Orleans, USA. FAU - Ouyang, J AU - Ouyang J FAU - Zhao, X AU - Zhao X FAU - Xie, J AU - Xie J FAU - Wang, J F AU - Wang JF FAU - Giles, T D AU - Giles TD LA - eng GR - NIAAA 09816/AA/NIAAA NIH HHS/United States GR - NIAAA 1P50-AA09803/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Pharmacol Exp Ther JT - The Journal of pharmacology and experimental therapeutics JID - 0376362 RN - 0 (Autacoids) RN - 0 (Endotoxins) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (RNA, Messenger) RN - 0 (Thionucleotides) RN - 0 (Tumor Necrosis Factor-alpha) RN - 3K9958V90M (Ethanol) RN - 63X7MBT2LQ (Bucladesine) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - 99Z2744345 (Ditiocarb) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - Y37441OBL1 (2-methylthio-ATP) SB - IM MH - Adenosine Triphosphate/analogs & derivatives/pharmacology MH - Animals MH - Autacoids/*metabolism MH - Bronchoalveolar Lavage Fluid/cytology MH - Bucladesine/pharmacology MH - Ditiocarb/pharmacology MH - Endotoxins/*metabolism MH - Enzyme Induction MH - Ethanol/blood/*metabolism MH - Lipopolysaccharides/pharmacology MH - Macrophages, Alveolar/drug effects/enzymology MH - Male MH - NF-kappa B/metabolism MH - Nitric Oxide Synthase/biosynthesis/*genetics MH - RNA, Messenger/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Thionucleotides/pharmacology MH - Tumor Necrosis Factor-alpha/metabolism MH - Up-Regulation/drug effects EDAT- 1997/08/01 00:00 MHDA- 1997/08/01 00:01 CRDT- 1997/08/01 00:00 PHST- 1997/08/01 00:00 [pubmed] PHST- 1997/08/01 00:01 [medline] PHST- 1997/08/01 00:00 [entrez] PST - ppublish SO - J Pharmacol Exp Ther. 1997 Aug;282(2):1044-54.